Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sara M Ibrahim"'
Publikováno v:
Alexandria Engineering Journal, Vol 67, Iss , Pp 241-255 (2023)
In various countries around the world, Transit-Oriented Development (TOD) is getting more attention as one of the most comprehensive planning approaches that can stimulate sustainable development, by encouraging the integration of land-use and transp
Externí odkaz:
https://doaj.org/article/7fb35ab3bad14a07ba6e9edd9f77c040
Publikováno v:
The Egyptian Journal of Otolaryngology, Vol 37, Iss 1, Pp 1-13 (2021)
Abstract Background Children with hearing impairment are deprived of their source of linguistic input which in turn leads to linguistic and prosodic deficits that negatively affect language and social development. Linguistic aspects other than prosod
Externí odkaz:
https://doaj.org/article/3aa1539ef9ff433b9480263c541e9045
Autor:
Abdelsattar M. Omar, Maan T. Khayat, Farid Ahmed, Yosra A. Muhammad, Azizah M. Malebari, Sara M. Ibrahim, Mohammad I. Khan, Dhaval K. Shah, Wayne E. Childers, Moustafa E. El-Araby
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tirbanibulin (KX2-391, KX-01), a dual non-ATP (substrate site) Src kinase and tubulin-polymerization inhibitor, demonstrated a universal anti-cancer activity for variety of cancer types. The notion that KX2-391 is a highly selective Src kinase inhibi
Externí odkaz:
https://doaj.org/article/74f0539c28fe4afaab248255f807b3c2
Autor:
Maan T. Khayat, Abdelsattar M. Omar, Farid Ahmed, Mohammad I. Khan, Sara M. Ibrahim, Yosra A. Muhammad, Azizah M. Malebari, Thikryat Neamatallah, Moustafa E. El-Araby
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Structural changes of small-molecule drugs may bring interesting biological properties, especially in the field of kinase inhibitors. We sought to study tirbanibulin, a first-in-class dual Src kinase (non-ATP competitive)/tubulin inhibitor because th
Externí odkaz:
https://doaj.org/article/539bc391ade147b39a5632057cf3fa93
Publikováno v:
International Journal of Transport Development and Integration. 6:378-398
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5ca48f78595ae2b2815c393f67e563d
https://doi.org/10.2495/tdi-v6-n4-378-398
https://doi.org/10.2495/tdi-v6-n4-378-398
Publikováno v:
WIT Transactions on The Built Environment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3033f5637c1e36db96854df9742f7bb0
https://doi.org/10.2495/ut210131
https://doi.org/10.2495/ut210131
Autor:
Pakinam Hassan, Sara M. Ibrahim
Publikováno v:
Contemporary Approaches in Urbanism and Heritage Studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f50aea393ccf89caf84302cd07bce296
https://doi.org/10.38027/n8iccaua2021226
https://doi.org/10.38027/n8iccaua2021226
Autor:
Adeel G. Chaudhary, Farid Ahmed, Sherin Bakhashab, Muhammed H. Al-Qahtani, Adel M. Abuzenadah, Jalaluddin Khan, Asad Muhammad Ilyas, Sajjad Karim, Peter Natesan Pushparaj, Sara M. Ibrahim
Publikováno v:
Oncology Reports
Multidrug resistance (MDR) is a major reason for the failure of acute myeloid leukemia (AML) therapy. Agents that reverse MDR and sensitize AML cells to chemotherapy are of great clinical significance. The present study developed Adriamycin (Adr)‑r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de3e1e1f6d3a356db2ef6a759771ef2
http://europepmc.org/articles/PMC6489006
http://europepmc.org/articles/PMC6489006
Effect of Levetiracetam Monotherapy on Hematological Parameters in Children with Idiopathic Epilepsy
Publikováno v:
The Medical Journal of Cairo University. 87:729-736
Background: Levetiracetam is broad spectrum, second generation antiepileptic drug which is highly tolerated in children with minor adverse events. Studies evaluating the effect of levetiracetam on hematological parameters have reported an unexplained
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cb9b1099b53518ad339a30794a44355
https://doi.org/10.21608/mjcu.2019.52530
https://doi.org/10.21608/mjcu.2019.52530
Autor:
Farid Ahmed, Mohammed H. Al-Qahtani, Sherin Bakhashab, Heba Abusamra, Jalaluddin Khan, Mamdooh Gari, Adel M. Abuzenadah, Peter Natesan Pushparaj, Sara M. Ibrahim, Sajjad Karim
Publikováno v:
Bioinformation
Acquisition of multi-drug resistance (MDR) is a major hindrance towards the successful treatment of cancers. Over expression of a range of ATP-dependent efflux pumps, particularly ABCB1 is a widely reported mechanism of cancer cell MDR. Approximately
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e329512b77d5ac23def396922b1f68
http://europepmc.org/articles/PMC6563671
http://europepmc.org/articles/PMC6563671